JY
TERN

Jeff Yass’s Terns Pharmaceuticals TERN Stock Holding History

Jeff Yass’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,016,400
Closed -$53.6M – 14514
2026
Q1 		$53.6M Buy
1,016,400
+546,800
+116% +$22.5M 0.01% 1240
2025
Q4 		$19M Buy
469,600
+299,300
+176% +$6.92M ﹤0.01% 2271
2025
Q3 		$1.28M Buy
170,300
+157,900
+1,273% +$1.01M ﹤0.01% 6746
2025
Q2 		$46.3K Sell
12,400
-113,300
-90% -$354K ﹤0.01% 12136
2025
Q1 		$347K Sell
125,700
-124,200
-50% -$507K ﹤0.01% 9736
2024
Q4 		$1.38M Buy
249,900
+800
+0.3% +$5.42K ﹤0.01% 6146
2024
Q3 		$2.08M Sell
249,100
-9,800
-4% -$80.6K ﹤0.01% 5198
2024
Q2 		$1.76M Buy
258,900
+157,500
+155% +$954K ﹤0.01% 5340
2024
Q1 		$665K Buy
101,400
+56,300
+125% +$368K ﹤0.01% 7816
2023
Q4 		$293K Buy
45,100
+13,400
+42% +$70.8K ﹤0.01% 9897
2023
Q3 		$159K Buy
31,700
+16,400
+107% +$104K ﹤0.01% 10483
2023
Q2 		$134K Buy
+15,300
New +$178K ﹤0.01% 10686

Other funds holding TERN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Jeff Yass's TERN Position: Q2 2026 in Review

Jeff Yass sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 521,571 shares — an estimated $27.5M sold.

Jeff Yass first reported a position in TERN in Q4 2022 and held it in 13 quarters. The position peaked at $27.5M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

  • Jeff Yass reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Jeff Yass sold 521,571 Terns Pharmaceuticals shares in Q2 2026, an estimated $27.5M.
  • Jeff Yass first reported a position in Terns Pharmaceuticals in Q4 2022 and held it in 13 quarters.
  • Jeff Yass's Terns Pharmaceuticals position peaked at $27.5M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.